Katie Ellias

Katie Ellias

DirectoratSAB Biotherapeutics· In proxies 2023–2025

Katie Ellias sits on 6 public boards.

Boards1

  • SAB BiotherapeuticsDirector · 0 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. SAB BiotherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -51%
  2. French-American Chamber of CommercePublic company
    • Director? – PresentNo stock prices for these years
  3. Capillary BiomedicalPublic company
    • Director? – PresentNo stock prices for these years
  4. DiogenXPublic company
    • Director? – PresentNo stock prices for these years
  5. TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  6. Veralox TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?